Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 known ✓ | P22748 | 2/20 | 0.40 |
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.37 |
| ▸ | CA1 known ✓ | P00915 | 1/20 | 0.30 |
| ▸ | CTSL | P07711 | 1/20 | 0.34 |
| ▸ | CPT2 | P23786 | 1/20 | 0.31 |
| ▸ | CPT1A | P50416 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7874080 | 0.96 | CA4 (0.37) | CA4CA2CTSLCPT2CPT1A | |
| SCHEMBL5794127 | 0.93 | CA4 (0.35) | CA4CA2CTSL | |
| SCHEMBL17594649 | 0.93 | CA4 (0.35) | CA4CA2CTSL | |
| SCHEMBL21862 | 0.72 | CA4 (0.48) | CA4CA2CTSLCPT2CPT1A | |
| SCHEMBL6239313 | 0.69 | CA4 (0.41) | CA4CA2CTSL | |
| SCHEMBL381960 | 0.68 | CA4 (0.44) | CA4CA2CTSL | |
| SCHEMBL1997913 | 0.67 | GABRR1 (0.38) | — | |
| SCHEMBL10381476 | 0.67 | CPB2 (0.41) | — | |
| SCHEMBL7807211 | 0.67 | GABRR1 (0.38) | — | |
| SCHEMBL7132158 | 0.65 | CA2 (0.48) | CA4CA2CTSLCPT2CPT1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6384003-B1 | SUBSTRATE IMPREGNATED WITH CLEANING COMPOUND | COLGATE-PALMOLIVE COMPANY | 2002-05-07 | — | — | US | claimed |
| US-11655411-B2 | Thermochemical composition for well cleanup | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2023-05-23 | — | — | US | disclosed |
| US-11518925-B2 | Downhole exothermic reaction well bore wall clean up method | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2022-12-06 | — | — | US | disclosed |
| US-20220220360-A1 | WELL BORE WALL CLEAN UP METHOD | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2022-07-14 | — | — | US | disclosed |
| US-20220220361-A1 | THERMOCHEMICAL COMPOSITION FOR WELL CLEANUP | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2022-07-14 | — | — | US | disclosed |
| US-11326090-B2 | Combined thermochemical and chelating agents useful for well cleanup | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2022-05-10 | — | — | US | disclosed |
| US-20210115322-A1 | COMBINED THERMOCHEMICAL AND CHELATING AGENTS USEFUL FOR WELL CLEANUP | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2021-04-22 | — | — | US | disclosed |
| US-10947483-B2 | Encapsulates | PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA (CH) | 2021-03-16 | — | — | US | disclosed |
| US-10604728-B2 | Encapsulates | PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA (CH) | 2020-03-31 | — | — | US | disclosed |
| US-20200071639-A1 | Encapsulates | PROCTER & GAMBLE INT OPERATIONS SA (CH) | 2020-03-05 | — | — | US | disclosed |
| WO-2000002995-A1 | SURFACTANT AGGLOMERATES | THE PROCTER & GAMBLE COMPANY (US) | 2000-01-20 | — | — | WO | disclosed |
| WO-2000002989-A1 | SURFACTANT AGGLOMERATES | THE PROCTER & GAMBLE COMPANY (US) | 2000-01-20 | — | — | WO | disclosed |
| EP-0972826-A1 | Process for producing a powder from a packaged tablet | THE PROCTER & GAMBLE COMPANY (US) | 2000-01-19 | — | — | EP | disclosed |
| EP-0972827-A1 | Process for producing a powder from a tablet | THE PROCTER & GAMBLE COMPANY (US) | 2000-01-19 | — | — | EP | disclosed |
| EP-0971030-A1 | Surfactant agglomerates | THE PROCTER & GAMBLE COMPANY (US) | 2000-01-12 | — | — | EP | disclosed |
| EP-0971028-A1 | Detergent tablet with high dissolution and mechanical characteristics | THE PROCTER & GAMBLE COMPANY (US) | 2000-01-12 | — | — | EP | disclosed |
| EP-0971029-A1 | Detergent tablet with high mechanical and dissolution characteristics | THE PROCTER & GAMBLE COMPANY (US) | 2000-01-12 | — | — | EP | disclosed |
| EP-0971023-A1 | Surfactant agglomerates | THE PROCTER & GAMBLE COMPANY (US) | 2000-01-12 | — | — | EP | disclosed |
| EP-0949327-A1 | Shape and strength of detergent tablets | THE PROCTER & GAMBLE COMPANY (US) | 1999-10-13 | — | — | EP | disclosed |
| WO-1999050381-A1 | SHAPE AND STRENGTH OF DETERGENT TABLETS | THE PROCTER & GAMBLE COMPANY (US) | 1999-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200071639-A1 | Encapsulates | LIPA, TTPA, CHMP4B | CA4 2796/4885CA2 3928/4885CA1 3244/4885 |
| US-10947483-B2 | Encapsulates | LIPA, TTPA, CHMP4B | CA4 2796/4885CA2 3928/4885CA1 3244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.